Simmons First Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.35M Buy
39,650
+24,022
+154% +$1.38M 0.27% 79
2015
Q3
$850K Buy
15,628
+111
+0.7% +$7.22K 0.21% 91
2015
Q2
$1.04M Buy
15,517
+174
+1% +$11.4K 0.26% 85
2015
Q1
$898K Buy
15,343
+2,473
+19% +$149K 0.22% 93
2014
Q4
$842K Buy
12,870
+1,138
+10% +$71.7K 0.21% 96
2014
Q3
$678K Sell
11,732
-16
-0.1% -$888 0.22% 85
2014
Q2
$663K Buy
11,748
+439
+4% +$23K 0.2% 93
2014
Q1
$581K Buy
11,309
+480
+4% +$24.3K 0.18% 92
2013
Q4
$572K Sell
10,829
-2,210
-17% -$109K 0.19% 88
2013
Q3
$583K Buy
13,039
+47
+0.4% +$2.08K 0.23% 80
2013
Q2
$537K Buy
+12,992
New +$568K 0.25% 69

Other funds holding ABBV

Simmons First Trust's ABBV Position: Q4 2015 in Review

Simmons First Trust increased its AbbVie (ABBV) stake by 154% in Q4 2015, buying an estimated $1.38M and bringing the position to 39,650 shares worth $2.35M. The position accounts for 0.27% of the portfolio, ranked #79.

Simmons First Trust first reported a position in ABBV in Q2 2013 and has held it in 11 quarters since. 1,635 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • Simmons First Trust held 39,650 shares of AbbVie worth $2.35M as of Q4 2015.
  • Simmons First Trust bought 24,022 AbbVie shares in Q4 2015, an estimated $1.38M.
  • AbbVie made up 0.27% of Simmons First Trust's portfolio in Q4 2015, its #79 holding.
  • Simmons First Trust first reported a position in AbbVie in Q2 2013 and has held it in 11 quarters since.
  • 1,635 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Simmons First Trust's 13F filing for Q4 2015, filed 1 Feb 2016.